| Functional aspect | Main finding / claim | Evidence type | Key quantitative / statistical details | Source with URL |
|---|---|---|---|---|
| Enzyme identity and catalytic function | CG13645 encodes Drosophila Nmnat (dNmnat), a bona fide nicotinamide mononucleotide adenylyltransferase in NAD biosynthesis; its catalytic center is highly conserved with other NMNATs. | Biochemical assay, genetics | Recombinant dNmnat showed NMNAT activity similar to human NMNAT3; catalytic mutants reduced activity to H30A 1.4%, W98G 22%, R224A 10.8%, and WR 0.9% of WT activity (pqac-00000003, pqac-00000005, pqac-00000006) | Zhai 2006, PLoS Biology. https://doi.org/10.1371/journal.pbio.0040416 |
| Primary enzymatic reaction / substrate specificity | Current understanding is that NMNAT enzymes convert NMN + ATP to NAD + PPi; recent reviews place dNmnat within the conserved NMNAT/NAD salvage axis whose loss elevates NMN and lowers NAD, predisposing axons to degeneration. | Review synthesis anchored to Drosophila/cross-species pathway work | Reviews state NMNAT enzymes produce NAD from NMN and ATP; after axotomy in the PAD pathway, NMN rises ~4-fold in 4–6 h and NAD+ falls >5-fold in systems where NMNAT loss is upstream of SARM1 activation (pqac-00000010, pqac-00000014) | Ademi 2023, Dissertation. https://doi.org/10.17863/cam.97015; Alexandris 2023, Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0350 |
| NAD-independent neuroprotection | dNmnat has a separable neuroprotective function: catalytically impaired proteins can still rescue degeneration in vivo, indicating that neuronal maintenance is not explained solely by NAD synthesis. | Genetics, morphology, ERG, imaging | Enzymatically impaired mutants with low residual activity, including WR at 0.9%, gave similar protection to WT in photoreceptor degeneration assays; quantification used 5 animals per genotype and 400 µm² ommatidia per animal (pqac-00000001, pqac-00000005, pqac-00000016) | Zhai 2006, PLoS Biology. https://doi.org/10.1371/journal.pbio.0040416 |
| Chaperone / proteostasis role | Evidence supports a moonlighting chaperone-like role for dNmnat/NMNAT beyond catalysis, including protection against misfolded-protein toxicity and links to protein quality control. | Review of primary genetic/proteostasis studies | Reported to bind Tau oligomers, promote ubiquitination and clearance, suppress Tau-induced degeneration, and reduce polyQ aggregate burden; C-terminal deletions impair chaperone activity, whereas catalytic mutant H30A can preserve chaperone-like protection in some contexts (pqac-00000000, pqac-00000007) | Ali 2011, dissertation/reviewed thesis text. URL not available in extracted context; Lee 2025, IJMS. https://doi.org/10.3390/ijms26189098 |
| Subcellular localization | dNmnat localizes strongly to neuronal nuclei and also to punctate synaptic and photoreceptor terminal structures, partially overlapping the active-zone marker nc82; expression is also seen in muscle nuclei. | Immunostaining, imaging | Adult lamina shows synaptic puncta co-localizing with nc82; adult brain and ventral nerve cord show strong nuclear signal. Figure summary indicates localization in photoreceptor terminals and neuronal nuclei (pqac-00000003, pqac-00000006, pqac-00000016) | Zhai 2006, PLoS Biology. https://doi.org/10.1371/journal.pbio.0040416 |
| Neural maintenance phenotype | Endogenous dNmnat is required for ongoing maintenance of mature neurons and synapses rather than gross initial development; loss causes progressive retinal and synaptic disorganization. | Genetics, ultrastructure, ERG | In lamina terminals, active zone number was not significantly changed despite degeneration: control 118 terminals, 3R41 93, 3R42 71; T-bar platform widths were significantly reduced; ERG responses declined with age and were nearly absent by 8 days in mutants (pqac-00000002, pqac-00000003, pqac-00000005, pqac-00000006) | Zhai 2006, PLoS Biology. https://doi.org/10.1371/journal.pbio.0040416 |
| Axon maintenance and injury response | dNmnat is essential for axonal integrity in vivo; depletion causes spontaneous retrograde dying-back degeneration, while overexpression preserves injured axons. | Nerve injury model, genetics, imaging, immunoblot | Wing-nerve injury assays used a 0–4 fragmentation score; loss of mitochondrial marker in severed axons occurred faster than cytoplasmic marker, with mitoGFP loss vs mChRFP at p<0.0001 and vs EB1GFP at p<0.001; n=7–9 wings per group. dNmnat overexpression preserved mitoGFP and MnSOD after injury across 3 experiments, with p<0.05 or p<0.01 depending on comparison (pqac-00000004) | Fang 2012, Current Biology. https://doi.org/10.1016/j.cub.2012.01.065 |
| Mitochondrial preservation | A major proximal readout of dNmnat protection in injured axons is maintenance of axonal mitochondria. | Imaging, immunoblot, genetics | In injured L1 nerves, mitoGFP became undetectable by day 20 without protection, whereas dNmnat upregulation markedly preserved mitochondrial markers and reduced degeneration (pqac-00000004) | Fang 2012, Current Biology. https://doi.org/10.1016/j.cub.2012.01.065 |
| Relationship to programmed axon degeneration pathway | Modern pathway models place NMNAT/dNmnat as the axon survival factor that antagonizes programmed axon degeneration; depletion of NMNAT activity is an initiating event upstream of SARM1/dSarm. | Review synthesis from Drosophila and vertebrate work | WldS/NMNAT gain of function can delay degeneration from about 1.5 days to 2–3 weeks; Nmnat2-null phenotypes can be rescued across the lifespan by removing SARM1 in mammals, supporting conserved antagonism between NMNAT and SARM1/dSarm (pqac-00000009, pqac-00000011, pqac-00000012) | Loreto 2024, Eye. https://doi.org/10.1038/s41433-024-03025-0; Alexandris 2023, Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0350 |
| Relationship with dSarm / SARM1 | dSarm/SARM1 is the pro-degenerative NADase activated when NMNAT function falls and the NMN/NAD ratio rises; NAD+ inhibits and NMN activates SARM1 allosterically. | Review, genetics, biochemical pathway synthesis | SARM1 activation can deplete neuronal NAD+ by ~90% within 90 min; cADPR rises 5–10-fold; in Sarm1 KO axons NAD+ remains largely unchanged and cADPR is nearly undetectable after injury. NMN can activate dSarm in Drosophila (pqac-00000013, pqac-00000014) | Alexandris 2023, Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0350 |
| Additional pathway components downstream or parallel to dNmnat loss | Axon degeneration induced by dNmnat loss converges on downstream execution factors such as Axundead (Axed); recent work also proposes a parallel ionic and osmotic sensor pathway involving dWnk. | Review and recent preprint | Axundead deletion prevented degeneration caused by axotomy, loss of dNmnat, or constitutively active dSarm; a 2024 preprint reports that dWnk is required for neurodegeneration induced by dNmnat depletion and converges with dSarm on Axed (pqac-00000015) | Alexandris 2023, Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0350 |
| Activity / light dependence | dNmnat-deficient degeneration is activity sensitive; reducing stimulation attenuates the phenotype, consistent with a maintenance role under physiological stress or load. | Genetics, environmental manipulation, ERG/histology | Blocking neuronal activity attenuated degeneration; dark rearing delayed retinal degeneration; constant light is a sensitized background in which even catalytically inactive dNmnat can protect morphology (pqac-00000001, pqac-00000003, pqac-00000006, pqac-00000016) | Zhai 2006, PLoS Biology. https://doi.org/10.1371/journal.pbio.0040416 |
| Recent Drosophila application: preserving severed axon function | dNmnat overexpression is now used experimentally to create long-lived, morphologically preserved severed axons that retain synaptic function, enabling study of local maintenance programs. | Primary 2024 study in Drosophila | Overexpressed dNmnat preserved severed projections for weeks and enabled evoked postsynaptic behavior; the preserved-state translatome implicated mTORC1, ubiquitination, and Ca2+ homeostasis genes in sustaining function (pqac-00000008) | Paglione 2024, EMBO Reports. https://doi.org/10.1038/s44319-024-00301-8 |
| Therapeutic / translational interpretation | Although the target gene here is Drosophila dNmnat, authoritative 2023–2024 reviews treat the conserved NMNAT-SARM1 axis as a major neuroprotection target for optic neuropathy and other axonopathies. | Expert review / translational analysis | Reviews cite remarkable or near-complete preclinical protection when targeting programmed axon death; strategies include SARM1 inhibitors, NMNAT stabilization, and NAD precursor supplementation. Small clinical studies of nicotinamide in glaucoma are noted as promising but not yet definitive for PAD causality (pqac-00000009, pqac-00000011, pqac-00000012, pqac-00000013) | Loreto 2024, Eye. https://doi.org/10.1038/s41433-024-03025-0; Alexandris 2023, Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0350 |
| Figure-level visual evidence | Authoritative figures show both nuclear and synaptic localization and rescue by catalytically inactive mutants, visually reinforcing the separation of catalytic and neuroprotective functions. | Image-based evidence from primary paper | Figure summary indicates localization in photoreceptor terminal puncta and neuronal nuclei; inactive H30A and WR mutants restore ERG, ommatidial morphology, and synaptic structure, with rhabdomere rescue quantified in degeneration models (pqac-00000016, pqac-00000017, pqac-00000018) | Zhai 2006, PLoS Biology. https://doi.org/10.1371/journal.pbio.0040416 |


*Table: This table condenses the strongest primary and recent review evidence for Drosophila melanogaster Nmnat/dNmnat, covering its enzymatic role in NAD metabolism, NAD-independent neuroprotective functions, localization, and integration into programmed axon degeneration pathways.*